Earth Science Tech (ETST) Accounts Payables (2012 - 2026)
Earth Science Tech (ETST) posted Accounts Payables of $1.2 million for Q1 2026, up 12.9% on a QoQ basis from $1.0 million in Q4 2025, and down 50.46% year-over-year from $2.3 million in Q1 2025.
Earth Science Tech (ETST) Accounts Payables (2012 - 2026) Analysis & Trends
Earth Science Tech's Accounts Payables history runs 13 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- Quarterly Accounts Payables fell 50.46% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 50.46% YoY) and the FY2026 annual result came in at $1.2 million, down 50.46% from the prior year.
- Accounts Payables was $1.2 million for Q1 2026 at Earth Science Tech, up from $1.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $2.3 million in Q1 2025 and bottomed at $46292.0 in Q4 2024.
- A 5-year average of $611702.6 and a median of $517137.0 in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables sank 92.81% — and 2025, when it surged 2101.32%.
- Earth Science Tech's Accounts Payables stood at $119331.0 in 2022, then soared by 439.2% to $643434.0 in 2023, then sank by 92.81% to $46292.0 in 2024, then jumped by 2101.32% to $1.0 million in 2025, then increased by 12.9% to $1.2 million in 2026.
- Business Quant data shows ETST's Accounts Payables at $1.2 million in Q1 2026, $1.0 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 960,062.00 |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 46,292.00 |
| Sep 30, 2024 | 392,227.00 |
| Jun 30, 2024 | 221,030.00 |
| Mar 31, 2024 | 530,724.00 |
| Dec 31, 2023 | 643,434.00 |
| Sep 30, 2023 | 347,432.00 |
| Jun 30, 2023 | 519,361.00 |
| Mar 31, 2023 | 517,137.00 |
| Dec 31, 2022 | 119,331.00 |
| Sep 30, 2022 | 175,524.00 |
| Jun 30, 2022 | 185,912.00 |
| Mar 31, 2022 | 202,270.00 |
| Dec 31, 2021 | 212,134.00 |
| Sep 30, 2021 | 172,328.00 |
| Jun 30, 2021 | 172,328.00 |